Cargando…
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS...
Autores principales: | Lim, Hui Xuan, Masomian, Malihe, Khalid, Kanwal, Kumar, Asqwin Uthaya, MacAry, Paul A., Poh, Chit Laa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/ https://www.ncbi.nlm.nih.gov/pubmed/35457159 http://dx.doi.org/10.3390/ijms23084341 |
Ejemplares similares
-
Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine
por: Ramanathan, Babu, et al.
Publicado: (2016) -
Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71)
por: Masomian, Malihe, et al.
Publicado: (2021) -
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2021) -
Impact of RNA Virus Evolution on Quasispecies Formation and Virulence
por: Mandary, Madiiha Bibi, et al.
Publicado: (2019) -
Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection
por: Masomian, Malihe, et al.
Publicado: (2020)